ATE187430T1 - In position 10 substituierte 1,8-dihydroxy-9(10h)-anthracenon pharmazeutika - Google Patents

In position 10 substituierte 1,8-dihydroxy-9(10h)-anthracenon pharmazeutika

Info

Publication number
ATE187430T1
ATE187430T1 AT94924761T AT94924761T ATE187430T1 AT E187430 T1 ATE187430 T1 AT E187430T1 AT 94924761 T AT94924761 T AT 94924761T AT 94924761 T AT94924761 T AT 94924761T AT E187430 T1 ATE187430 T1 AT E187430T1
Authority
AT
Austria
Prior art keywords
substituted
anthracenone
pharmaceutics
dihydroxy
anthracenones
Prior art date
Application number
AT94924761T
Other languages
English (en)
Inventor
Klaus Muller
Dieter Gurster
Wolfgang Wiegrebe
Susanne Peters
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE187430T1 publication Critical patent/ATE187430T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/34—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups polycyclic
    • C07C65/36—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups polycyclic containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT94924761T 1993-07-19 1994-07-13 In position 10 substituierte 1,8-dihydroxy-9(10h)-anthracenon pharmazeutika ATE187430T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/092,854 US5426197A (en) 1993-07-19 1993-07-19 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals

Publications (1)

Publication Number Publication Date
ATE187430T1 true ATE187430T1 (de) 1999-12-15

Family

ID=22235495

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94924761T ATE187430T1 (de) 1993-07-19 1994-07-13 In position 10 substituierte 1,8-dihydroxy-9(10h)-anthracenon pharmazeutika

Country Status (12)

Country Link
US (4) US5426197A (de)
EP (1) EP0664780B1 (de)
JP (1) JPH08502521A (de)
AT (1) ATE187430T1 (de)
AU (1) AU671560B2 (de)
CA (1) CA2145067A1 (de)
DE (1) DE69422013T2 (de)
FI (1) FI951252A7 (de)
IL (1) IL110187A0 (de)
NO (1) NO306208B1 (de)
WO (1) WO1995003266A1 (de)
ZA (1) ZA945153B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426197A (en) * 1993-07-19 1995-06-20 Teva Pharmaceutical Industries, Ltd. 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals
US5952390A (en) * 1993-07-19 1999-09-14 Teva Pharmaceutical Industries Ltd. 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals
US6214915B1 (en) 1998-12-10 2001-04-10 General Electric Company Stabilized thermoplastic compositions
EP1435894A4 (de) * 2001-07-23 2005-07-06 Galileo Pharmaceuticals Inc Zytoprotektive verbindungen, pharmazeutische und kosmetische formulierungen und verfahren
US6596996B1 (en) * 2001-07-24 2003-07-22 The Board Of Regents For Oklahoma State University Optical spectral reflectance sensor and controller
CN100509740C (zh) * 2006-06-06 2009-07-08 中国科学院广州化学研究所 10,10-二苄基蒽酮及其衍生物和合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI57743C (fi) * 1979-03-29 1980-10-10 Orion Yhtymae Oy Foerfarande foer framstaellning av nya 1,8-dihydroxi-10-acyl-9-antroner mot psoriasis
FR2492372A1 (fr) * 1980-10-21 1982-04-23 Cird Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
US4558069A (en) * 1981-02-10 1985-12-10 Groupement D'interet Economique Dit: Centre International De Recherches Dermatologiques C.I.R.D. 1,8-Dihydroxy-9-anthrones derivatives substituted in the 10-position by an unsaturated radical used in human medicine
FR2499556B1 (de) * 1981-02-10 1983-03-25 Cird
FI66585C (fi) * 1983-05-18 1984-11-12 Orion Yhtymae Oy Foerfarande foer framstaellning av saerskilt vid behandling avsoriasis anvaendbara 1,8-dihydroxi-10-acyl-9-antroner
US4843097A (en) * 1984-06-13 1989-06-27 Groupement D'interet Economique Dit: Centre International De Recherches Dermatologiques C.I.R.D. 10-aryl-1,8-dihydroxy-9-anthrones and their esters, process for preparing same, and use of same in human and veterinary medicine and in cosmetics
FR2565966B1 (fr) * 1984-06-13 1986-08-29 Cird Aryl-10 dihydroxy-1,8 anthrones et leurs esters, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2566772B1 (fr) * 1984-06-29 1986-11-14 Cird Diacyloxy-1,8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2567402B1 (fr) * 1984-07-12 1988-07-01 Cird Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
FR2580631B1 (fr) * 1985-04-17 1987-05-29 Cird Hydroxy-1 acyloxy-8 acyl-10 anthrones, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
JPH03502686A (ja) * 1987-10-22 1991-06-20 ザ　ビクトリア　ユニヴアーシテイ　オブ　マンチエスター アントラキノン系の新規化合物
DE4231636A1 (de) * 1992-09-22 1994-03-24 Beiersdorf Ag Neue in 10-Stellung substituierte Anthron- und Anthracen-Derivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende pharmazeutische oder kosmetische Mittel und deren Verwendung
US5426197A (en) * 1993-07-19 1995-06-20 Teva Pharmaceutical Industries, Ltd. 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals

Also Published As

Publication number Publication date
FI951252L (fi) 1995-04-18
WO1995003266A1 (en) 1995-02-02
JPH08502521A (ja) 1996-03-19
EP0664780B1 (de) 1999-12-08
ZA945153B (en) 1995-02-24
NO306208B1 (no) 1999-10-04
FI951252A7 (fi) 1995-04-18
IL110187A0 (en) 1994-10-21
AU671560B2 (en) 1996-08-29
DE69422013D1 (de) 2000-01-13
CA2145067A1 (en) 1995-02-02
DE69422013T2 (de) 2000-07-13
AU7493594A (en) 1995-02-20
FI951252A0 (fi) 1995-03-16
US5426197A (en) 1995-06-20
EP0664780A1 (de) 1995-08-02
US5661187A (en) 1997-08-26
US6127426A (en) 2000-10-03
NO951034D0 (no) 1995-03-17
US5844004A (en) 1998-12-01
NO951034L (no) 1995-03-17

Similar Documents

Publication Publication Date Title
FI922919A0 (fi) Mild vaordschampo med hoeg skumnivao.
FI910352L (fi) Topikal sammansaettning.
ES2192839T3 (es) Timosina beta 4 oxidada.
FI954598A0 (fi) Radiofarmaseuttisea formulaatioita, joissa on ei-stanno-pelkistimiä
ATE187430T1 (de) In position 10 substituierte 1,8-dihydroxy-9(10h)-anthracenon pharmazeutika
DE69112897D1 (de) Resist-Zusammensetzung.
NO912681L (no) Anordning for sammenfoeyning av delkomponenter i moebler.
FR2679302B1 (fr) Ecrou elastique perfectionne.
MX9205362A (es) Composiciones herbicidas sinergisticas.
ITMI931806A0 (it) Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica , loro uso e composizioni farmaceutiche che li contengono
FR2670254B1 (fr) Ecrou elastique.
IT229726Y1 (it) Corpo di proiettore multiforme
ES1021299Y (es) Taburete perfeccionado.
ES1016659Y (es) Futbolin perfeccionado.
ES1017534Y (es) Futbolin perfeccionado.
ES1025693Y (es) Futbolin perfeccionado.
ES1024456Y (es) Futbolin perfeccionado.
ES1024853Y (es) Futbolin perfeccionado.
MX9204709A (es) Agentes terapeuticos.
NO901474D0 (no) Medisinsk sproeyte med beskyttelse.
ES1020740Y (es) Sofa perfeccionado.
ES1025740Y (es) Sofa-cama perfeccionado.
ES1014654Y (es) Mesa de billar perfeccionada.
ES1016025Y (es) Mesa de billar perfeccionada.
DE69111219D1 (de) Ionomerzusammensetzung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee